Apple Tree says its biotechs face ‘imminent collapse’; Advocates urge J&J to proceed with eye gene therapy; AbbVie buys in vivo CAR-T maker Capstan; and more
Summary by endpoints.news
1 Articles
1 Articles
All
Left
Center
Right
Apple Tree says its biotechs face ‘imminent collapse’; Advocates urge J&J to proceed with eye gene therapy; AbbVie buys in vivo CAR-T maker Capstan; and more
Happy July 4th weekend! We’ve got a condensed version of Endpoints Weekly for you this week, so let’s dive right into the biggest stories. First up, a key investor for Apple Tree Partners is allegedly ...
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium